Abstract |
Various topical and systemic treatments have shown efficacy in plaque and palmoplantar psoriasis; however, studies regarding efficacy in inverse psoriasis are few. The authors present a case of a patient with severe inverse psoriasis who was successfully treated with efalizumab, resulting in complete and sustained remission during prolonged maintenance therapy.
|
Authors | Dornechia George, Ted Rosen |
Journal | Journal of drugs in dermatology : JDD
(J Drugs Dermatol)
Vol. 8
Issue 1
Pg. 74-6
(Jan 2009)
ISSN: 1545-9616 [Print] United States |
PMID | 19180901
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Dermatologic Agents
- efalizumab
|
Topics |
- Aged
- Antibodies, Monoclonal
(administration & dosage, therapeutic use)
- Antibodies, Monoclonal, Humanized
- Dermatologic Agents
(administration & dosage, therapeutic use)
- Humans
- Injections, Subcutaneous
- Male
- Psoriasis
(drug therapy)
- Remission Induction
- Treatment Outcome
|